These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1525 related articles for article (PubMed ID: 32103760)

  • 21. Characterization of CD103
    Han L; Gao QL; Zhou XM; Shi C; Chen GY; Song YP; Yao YJ; Zhao YM; Wen XY; Liu SL; Qi YM; Gao YF
    Cancer Immunol Immunother; 2020 Aug; 69(8):1493-1504. PubMed ID: 32285170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma.
    Yang K; Xie Y; Xue L; Li F; Luo C; Liang W; Zhang H; Li Y; Ren Y; Zhao M; Wang W; Liu J; Shen X; Zhou W; Fei J; Chen W; Gu W; Wang L; Li F; Hu J
    J Transl Med; 2023 Jan; 21(1):26. PubMed ID: 36641471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
    Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
    Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC.
    Chen X; Zhou J; Wang Y; Wang X; Chen K; Chen Q; Huang D; Jiang R
    Oncogene; 2024 Aug; 43(33):2517-2530. PubMed ID: 39004633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
    Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
    Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-Derived Exosomal miR-143-3p Induces Macrophage M2 Polarization to Cause Radiation Resistance in Locally Advanced Esophageal Squamous Cell Carcinoma.
    Gao LR; Zhang J; Huang N; Deng W; Ni W; Xiao Z; Liu M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
    Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
    Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSF1 expression in tumor-associated macrophages promotes tumor cell proliferation and indicates poor prognosis in esophageal squamous cell carcinoma.
    Li Y; Li Q; Liu J; Huang Y; Mao J; Zhang G
    Clin Transl Oncol; 2023 Jun; 25(6):1682-1689. PubMed ID: 36586067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor associated macrophages in esophageal squamous carcinoma: Promising therapeutic implications.
    Zhang J; Dong Y; Di S; Xie S; Fan B; Gong T
    Biomed Pharmacother; 2023 Nov; 167():115610. PubMed ID: 37783153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of signal regulatory protein alpha (SIRPα) expression in esophageal squamous cell carcinoma.
    Koga N; Hu Q; Sakai A; Takada K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Oki E; Oda Y; Mori M
    Cancer Sci; 2021 Aug; 112(8):3018-3028. PubMed ID: 34009732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic and clinical significance of tumor-associated macrophages in esophageal squamous cell carcinoma after surgery: do biomarkers and distributions matter?
    Yi B; Zeng J; Li L; Zhang J; Chen Y; Gao Y
    Biosci Rep; 2024 Apr; 44(4):. PubMed ID: 38501293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
    Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
    Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
    Li S; Liu Z; Chen Q; Chen Y; Ji S
    Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma.
    Yuan X; Liu K; Li Y; Zhang AZ; Wang XL; Jiang CH; Liang WH; Zhang HJ; Pang LJ; Li M; Yang L; Qi Y; Zheng Q; Li F; Hu JM
    Clin Transl Oncol; 2021 Nov; 23(11):2382-2393. PubMed ID: 34075547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis.
    Li J; Zeng Z; Jiang X; Zhang N; Gao Y; Luo Y; Sun W; Li S; Ren J; Gong Y; Xie C
    Sci Rep; 2020 Oct; 10(1):18589. PubMed ID: 33122682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis.
    Chen J; Zhao D; Zhang L; Zhang J; Xiao Y; Wu Q; Wang Y; Zhan Q
    Drug Resist Updat; 2024 Mar; 73():101055. PubMed ID: 38387281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
    Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
    BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 77.